Shares of Hims & Hers Health Inc. were surging Wednesday after the telehealth company announced new treatment plans for women experiencing menopause and perimenopause.

Hims & Hers

HIMS, which had previously gained notoriety for offering alternative GLP-1 weight-loss treatments, is now taking aim at this large and potentially highly lucrative market. The company’s move comes a few months after rival WeightWatchers WW did the same.